Data / Form D filings / TCM Life Science Inc.
TCM Life Science Inc.: Form D filing
TCM Life Science Inc., a biotechnology company in Newark, DE, filed a Form D with the SEC in 2026. The latest, on October 26, 2026, reports $16,666 sold of an offering with no set size to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 131 CONTINENTAL DRIVE, SUITE 301, Newark, DE, 19713
- Phone
- 886226972628
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2160964
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | New notice | Indefinite | $16,666 | 2 | Oct 12, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ya-Chun Wang | Executive Officer, Director | |
| Huan-Chin Hsu | Director |
Other biotechnology companies in Delaware that filed recently
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Oct 26, 2026 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TCM Life Science Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.